Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions



Gibson, Andrew, Deshpande, Pooja, Campbell, Chelsea N, Krantz, Matthew S, Mukherjee, Eric, Mockenhaupt, Maja, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Palubinsky, Amy M and Phillips, Elizabeth J
(2023) Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 151 (2). 289-+. ISSN 0091-6749, 1097-6825

[thumbnail of Accepted with figures.pdf] Text
Accepted with figures.pdf - Author Accepted Manuscript

Download (1MB) | Preview

Abstract

Severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome, toxic epidermal necrolysis (SJS/TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS) cause significant morbidity and mortality and impede new drug development. HLA class I associations with SJS/TEN and drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome have aided preventive efforts and provided insights into immunopathogenesis. In SJS/TEN, HLA class I–restricted oligoclonal CD8+ T-cell responses occur at the tissue level. However, specific HLA risk allele(s) and antigens driving this response have not been identified for most drugs. HLA risk alleles also have incomplete positive and negative predictive values, making truly comprehensive screening currently challenging. Although, there have been key paradigm shifts in knowledge regarding drug hypersensitivity, there are still many open and unanswered questions about SCAR immunopathogenesis, as well as genetic and environmental risk. In addition to understanding the cellular and molecular basis of SCAR at the single-cell level, identification of the MHC-restricted drug-reactive self- or viral peptides driving the hypersensitivity reaction will also be critical to advancing premarketing strategies to predict risk at an individual and drug level. This will also enable identification of biologic markers for earlier diagnosis and accurate prognosis, as well as drug causality and targeted therapeutics.

Item Type: Article
Uncontrolled Keywords: AGEP, altered peptide, DIHS, DRESS, HLA, SCAR, SJS, T-cell, TEN
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Inst. Systems, Molec & Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 20 Aug 2024 08:55
Last Modified: 22 May 2026 16:37
DOI: 10.1016/j.jaci.2022.12.005
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3170549
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.